Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

EMA committee backs approval of Brilique 60 mg for patients with history of heart attack

Dec. 21, 2015

Research Triangle Institute announces APJ agonists

Dec. 21, 2015

Isis Pharmaceuticals confirms initiation of phase II study of ISIS-TTR-Rx

Dec. 18, 2015

Sanford-Burnham Medical Research Institute introduces apelin receptor agonists

Dec. 18, 2015

Merck & Co. responds after conclusion of FDA advisory committee meeting on Vytorin

Dec. 18, 2015

GBT-1118 improves hypoxia survival in mice

Dec. 17, 2015

CardioPharma plans pharmacodynamic trial of triple combination CP-101

Dec. 16, 2015

Cardioxyl Pharmaceuticals and Johns Hopkins University patent nitroxyl donors

Dec. 15, 2015

Ularitide receives FDA fast track designation for acute decompensated heart failure

Dec. 14, 2015

Pluristem and United Therapeutics end licensing agreement for PLX-PAD

Dec. 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.